These findings, in addition to the fact that Pten deletion is more common than other PI3K/Akt alterations, suggests that Pten contributes to prostate oncogenesis through multiple mechanisms beyond activation of PI3K/Akt signaling. The gene discussed is PIK3CA; the disease is prostatitis.